Benzene and substituted derivatives (total related compounds in database, current show from 1 to 10) |
|
|
1-phenyl-3-[4-(phenylsulfamoyl)phenyl]thiourea |
|
Escherichia Salmonella |
Regulation QseBC |
Preclinical (in vivo) Preclinical (in vivo) |
Rasko DA, et al. 2008. Science
|
|
3-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
OH
OH
HO
HO
H
3
C
OH
H
O
NH
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
3-[4-[(R)-hydroxy-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
CH
3
HO
OH
OH
OH
CH
3
HO
H
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
3-[4-[(S)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
OH
HO
HO
OH
H
3
C
OH
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
3-[4-[(S)-hydroxy-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
CH
3
HO
OH
OH
OH
CH
3
HO
H
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
3-[4-[(S)-hydroxy-[3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide |
Depiction based on curated SMILES
O
O
CH
3
NH
O
OH
O
CH
3
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
Methyl 3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]sulfanylphenyl]benzoate |
Depiction based on curated SMILES
OH
OH
HO
HO
H
3
C
O
S
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
Methyl 3-[4-[[(2S,3S,4S,5S,6R)-3,4,5-trihyd roxy-6-(hyd roxymethyl)tetrahydropyran-2-yl]amino]phenyl]benzoate |
Depiction based on curated SMILES
OH
OH
HO
HO
H
3
C
O
N
H
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
N-methyl-3-[3-methyl-4-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]benzamide |
Depiction based on curated SMILES
H
H
H
H
H
O
HO
OH
OH
OH
CH
3
O
NH
CH
3
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
N-methyl-3-[4-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]benzamide |
Depiction based on curated SMILES
OH
OH
HO
HO
H
3
C
O
O
NH
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
| | |
|
NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.
 |
Back to top |
|